concord
发表于 2025-3-21 16:45:13
书目名称Challenges and Solutions Against Visceral Leishmaniasis影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0223425<br><br> <br><br>书目名称Challenges and Solutions Against Visceral Leishmaniasis影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0223425<br><br> <br><br>书目名称Challenges and Solutions Against Visceral Leishmaniasis网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0223425<br><br> <br><br>书目名称Challenges and Solutions Against Visceral Leishmaniasis网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0223425<br><br> <br><br>书目名称Challenges and Solutions Against Visceral Leishmaniasis被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0223425<br><br> <br><br>书目名称Challenges and Solutions Against Visceral Leishmaniasis被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0223425<br><br> <br><br>书目名称Challenges and Solutions Against Visceral Leishmaniasis年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0223425<br><br> <br><br>书目名称Challenges and Solutions Against Visceral Leishmaniasis年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0223425<br><br> <br><br>书目名称Challenges and Solutions Against Visceral Leishmaniasis读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0223425<br><br> <br><br>书目名称Challenges and Solutions Against Visceral Leishmaniasis读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0223425<br><br> <br><br>
Allege
发表于 2025-3-21 22:26:29
Essentials in Leishmaniasis Elimination,there is no vaccine approved currently against any type of Leishmaniasis for use in humans. Recent studies have reported novel approaches to vaccine development and the important role of the innate immune system and its interaction with . for the development of an effective vaccine against leishmani
袋鼠
发表于 2025-3-22 04:12:20
Post Kala-Azar Dermal Leishmaniasis: Diagnosis and Treatment,or an accurate and rapid diagnosis of PKDL, loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA) have been used. Such assays can be used to assess the efficacy of new antileishmanial drugs and to assess the effectiveness of cures. The standard treatment for PK
filicide
发表于 2025-3-22 05:55:46
Emergence of Novel , Genetic Variants: A New Challenge to the Ongoing Leishmaniasis Elimination Pros forms are on an increase with reports of atypical CL caused by . genetic variants from the Indian subcontinent. The phenomenon points toward the possible emergence of novel parasite variants and calls for molecular surveillance of the heterogeneous parasite isolates from the known and newer endemi
真实的人
发表于 2025-3-22 11:58:03
http://reply.papertrans.cn/23/2235/223425/223425_5.png
tangle
发表于 2025-3-22 16:51:03
http://reply.papertrans.cn/23/2235/223425/223425_6.png
tangle
发表于 2025-3-22 20:51:46
http://reply.papertrans.cn/23/2235/223425/223425_7.png
精密
发表于 2025-3-22 22:42:36
http://reply.papertrans.cn/23/2235/223425/223425_8.png
mediocrity
发表于 2025-3-23 02:43:00
Miltefosine Unresponsiveness in Visceral Leishmaniasis,ally in endemic areas. Treatment outcome is governed by several factors related to host-parasite and drug kinetics. Host-related factors include host immunity or host nutritional status; for example, enhanced Th1-type response is crucial for effective treatment outcomes. Factors related to the drug,
monologue
发表于 2025-3-23 07:20:26
http://reply.papertrans.cn/23/2235/223425/223425_10.png